rTMS is not currently a funded procedure under OHIP. However, the UHN rTMS Clinic does not currently charge patients for treatment. The clinic has a number of research studies underway at any given time, and research funds are available to cover the full cost of treatment for participants in these studies. The majority of people who are good candidates for rTMS can be offered participation in one of the studies currently underway.  Should you be ineligible to participate in one of the ongoing clinical trials, you may still be able to receive treatment at no cost. A small travel stipend is also available for participants. 
 
Below is a list of our current trials, and the contact information for the study coordinator, who can answer any questions you may have about the study, including the referral and intake process.  Alternatively, you can speak with someone from our research team at (416) 603-5800 x 5494.


Accelerated rTMS treatment and biological markers of treatment response: investigating tolerability, efficacy and predictability of effect using rTMS, EEG and HRV

Study Coordinator: 

Ryan Zhou,
ryan.zhou@uhn.ca

Eligibility:

  • Diagnosis of Major Depressive Disorder

  • No results following a previous course of treatment such as pharmaceuticals or psychotherapy

  • Male or Female, aged 18-65 years old

Treatment Protocol:

  • 1 week (5 weekdays) of 8 daily rTMS sessions, with 45-minute breaks in between sessions

  • EEG recordings and clinical assessments will be conducted prior to starting treatment, and after treatment has been completed


Eligibility:

  • Diagnosis of Anorexia Nervosa – binge/purge subtype or Bulimia Nervosa for at least 6 months

  • Have not seen results following a previous course of treatment for the eating disorder such as pharmaceuticals or psychotherapy

  • Male or Female, aged 18-65 years old

Treatment Protocol:

  • 6 weeks of daily rTMS sessions administered during weekdays only, for a total of 30 rTMS sessions.

  • An MRI will be taken both prior to and following the course of treatment.

  • Weekly assessments throughout treatment and four additional follow-up assessments will be conducted post-treatment at 1 week, 1 month, 3 months, 6 months.

The Dorsomedial Prefrontal Cortex as a target in treatment-resistant Bulimia Nervosa and Anorexia Nervosa: investigating target engagement, dosing, reliability and duration of effect using rTMS, fMRI, and a sham controlled arm.


Study Coordinator:

Eileen Lam, eileen.lam@uhn.ca


Eligibility:

  • History of Major Depressive Disorder

  • Most recent depressive episode treated with acute rTMS

  • Male or Female, aged 18-65 years old

 Treatment Protocol:

  • 6 months of at home tDCS sessions

    • 3 sessions per week for first 3 months

    • 1 session per week for next 3 months

  • Weekly in-person sessions for 1 month; Bi-weekly in-person sessions for next 5 months

Step-Down Neurostimulation to Maintain Response After Repetitive Transcranial Magnetic Stimulation (rTMS) using Transcranial direct current stimulation (tDCS)

Study Coordinator:

Meaghan Todd,
meaghan.todd@uhnresearch.ca


A Randomized Controlled Trial Comparing 3 Different Patterns of Repetitive Transcranial Magnetic Stimulation in the Treatment of Refractory Depression: a 3 Arm Double Blind Study Condition.

Study Coordinator:

Terri Cairo, terri.cairo@uhn.ca

Condition:

Major depressive disorder

Demographic:

Males and females aged 18-65


For more information about our clinic's research activities, please visit http://rtmslab.ca